| Literature DB >> 26058561 |
Josephine Merker1,2, Matthias Hartmann3, Florian Kreuzpointner4, Ansgar Schwirtz5, Johannes-Peter Haas6.
Abstract
BACKGROUND: Patients suffering from juvenile idiopathic arthritis (JIA) frequently have affected ankle joints, which can lead to foot deformities such as pes planovalgus (JIA-PPV). Usually, JIA-PPV is diagnosed by examining the foot in non-weightbearing or in weightbearing, static condition. However, functional limitations typically appear during dynamic use in daily activities such as walking. The aim of this study was to quantify the pathophysiology of JIA-PPV in both static and dynamic condition, i.e. in upright standing and during the stance phase of walking using three-dimensional (3d) gait analysis.Entities:
Mesh:
Year: 2015 PMID: 26058561 PMCID: PMC4461984 DOI: 10.1186/s12969-015-0022-z
Source DB: PubMed Journal: Pediatr Rheumatol Online J ISSN: 1546-0096 Impact factor: 3.054
Fig. 1Juvenile idiopathic arthritis induced pes planovalgus in standing position. The foot is prepared with skin markers according to the Oxford Foot Model
Anthropometrical characteristics and spatio-temporal parameters of JIA pes planovalgus patients (JIA-PPV) and control group (CG)
| JIA-PPV | CG | ||||
|---|---|---|---|---|---|
| (n = 11) | (n = 14) | ||||
| Parameter | Median | Q25/Q75 | Median | Q25/Q75 |
|
| Age (y) | 11.7 | 9.7/14.0 | 10.9 | 9.9/12.6 | 0.784 |
| Height (m) | 1.46 | 1.37/1.59 | 1.47 | 1.4/1.6 | >0.999 |
| Weight (kg) | 44.1 | 31.0/55.8 | 39.9 | 30.4/45.4 | 0.511 |
| Body Mass Index (kg/m2) | 19.0 | 15.9/21.8 | 17.7 | 15.4/19.1 | 0.291 |
| Walking speed (m/s) | 1.14 | 1.09/1.21 | 1.28 | 1.20/1.34 | 0.075 |
| Step length (m) | 0.60 | 0.51/0.66 | 0.62 | 0.59/0.66 | 0.291 |
| Step width (m) | 0.10 | 0.08/0.11 | 0.08 | 0.06/0.10 | 0.166 |
| Foot off (%) | 59.4 | 59.0/60.2 | 59.3 | 58.7/59.9 | 0.477 |
*Statistically significant as p < 0.05
Characteristics of JIA pes planovalgus patients (JIA-PPV)
| JIA-PPV | ||||
|---|---|---|---|---|
| Parameter | n | Median | Q25/Q75 | |
| JIA sub-types | ||||
| Systemic arthritis | 2 | - | - | |
| Persistent oligoarthritis | 2 | - | - | |
| Extended oligoarthritis | 4 | - | - | |
| Polyarthritis (RF neg.) | 2 | - | - | |
| Enthesitis-related arthritis | 1 | - | - | |
| JIA affected joints of the lower extremities | ||||
| Hip left/right | 5/4 | - | - | |
| Knee left/right | 9/9 | - | - | |
| Ankle left/right | 10/10 | - | - | |
| Midfoot left/right | 3/3 | - | - | |
| Toe left/right | 3/2 | - | - | |
| Drugs | ||||
| Non-steroidal anti-inflammatory drugs | 4 | - | - | |
| Disease-modifying anti-rheumatic drugs | 9 | - | - | |
| Biologicals | 7 | - | - | |
| Physician global assessment of overall disease activity (VAS 0-10 cm) | 11 | 4.1 | 0.9/7.1 | |
| Duration of disease (y) | 11 | 7.5 | 5.6/10.7 | |
| Pain intensity (VAS 0-10 cm) | 11 | 1.5 | 0.0/1.6 | |
Fig. 2Classification of a normal gait cycle (modified to Perry 1992, p. 2–4) [20]
Fig. 3Example of a footprint and the calculation of the Arch Index. The point j and k represent the length of the footprint, excluding the toes. A, B and C represent equal thirds, which are divided by parallel lines perpendicular to the line jk. The arch index is calculated as the ratio of the midfoot area (B) relative to the total area (A + B + C) excluding the toes [19]
Kinematic and kinetic outcome values of upright standing and stance phase of walking. Data of JIA pes planovalgus patients (JIA-PPV) and healthy control group (CG)
| JIA-PPV (n = 11) | CG (n = 14) | |||||||
|---|---|---|---|---|---|---|---|---|
| Parameter | Median | Q25/Q75 |
| Median | Q25/Q75 |
| ||
| Hindfoot to tibia motion (°) | ||||||||
| DF/PF | static | 1.8 | −2.5/4.1 | 4.0 | 2.2/6.9 | 0.033* | ||
| dorsiflexion (max in TSt) | 2.5 | −0.1/5.7 | 10.0 | 6.2/11.2 | <0.001* | |||
| plantarflexion (max in PSw) | −14.1 | −17.7/-5.5 | −7.1 | −11.3/-4.9 | 0.120 | |||
| ROM (TSt to PSw) | 15.4 | 17.7/10.1 | 17.0 | 19.4/14.5 | 0.434 | |||
| IV/EV | static | −9.2 | −12.5/-5.3 | −0.5 | −3.4/1.4 | <0.001* | ||
| in/eversion (IC) | −6.4 | −9.1/-2.3 | 4.0 | 0.7/6.6 | <0.001* | |||
| eversion (max in MSt) | −11.1 | −15.0/-9.0 | −2.4 | −3.2/-0.8 | <0.001* | |||
| inversion (max in PSw) | −0.2 | −5.1/2.1 | 10.5 | 5.2/12.8 | <0.001* | |||
| ROM (IC to MSt) | 5.4 | 7.1/4.3 | 5.7 | 7.6/3.7 | 0.767 | |||
| ROM (MSt to PSw) | 11.0 | 8.3/13.6 | 12.2 | 9.6/15.0 | 0.317 | |||
| static vs. max in MSt | −9.2 | −12.5/-5.3 | 0.021* | −0.5 | −3.4/1.4 | 0.14 | ||
| −11.1 | −15.0/-9.0 | −2.4 | −3.2/-0.8 | |||||
| Forefoot to hindfoot motion (°) | ||||||||
| DF/PF | static | 10.1 | 6.1/14.2 | 5.6 | 4.1/6.8 | 0.014* | ||
| dorsiflexion (max in TSt) | 18.0 | 11.5/21.2 | 13.4 | 10.7/14.5 | 0.058 | |||
| plantarflexion (max in PSw) | 3.2 | −4.2/5.9 | −4.8 | −6.8/-2.7 | 0.005* | |||
| ROM (TSt to PSw) | 14.8 | 19.7/12.1 | 17.7 | 19.0/15.3 | 0.244 | |||
| SP/PR | static | 14.3 | 12.4/19.5 | 5.5 | 2.0/8.2 | <0.001* | ||
| supination (max in LR) | 17.8 | 12.0/20.9 | 5.4 | 1.8/7.4 | <0.001* | |||
| pronation (max in TSt) | 8.8 | 7.1/13.9 | −0.1 | −1.5/1.8 | <0.001* | |||
| ROM (LR to TSt) | 7.0 | 8.4/4.5 | 4.3 | 6.2/3.6 | 0.006* | |||
| Medial longitudinal arch | ||||||||
| AH (%) | static | 20.7 | 19.0/22.0 | 21.6 | 20.5/22.3 | 0.274 | ||
| minimum (MSt) | 21.4 | 18.0/23.6 | 20.4 | 19.5/21.5 | 0.767 | |||
| maximum (MSt) | 21.6 | 18.5/23.8 | 21.3 | 20.1/22.2 | 0.809 | |||
| ROM (min to max MSt) | 0.5 | 0.2/0.8 | 0.6 | 0.4/0.9 | 0.501 | |||
| static vs. min in MSt | 20.7 | 19.0/22.0 | 0.929 | 21.6 | 20.5/22.3 | 0.096 | ||
| 21.4 | 18.0/23.6 | 20.4 | 19.5/21.5 | |||||
| AI | (MSt) | 0.25 | 0.23/0.27 | 0.22 | 0.17/0.23 | 0.007* | ||
| Foot progression angle (°) | ||||||||
| static | −5.8 | −8.4/-0.9 | −6.1 | −9.1/-3.7 | 0.511 | |||
| maximum (MSt) | −6.0 | −10.5/-3.0 | −4.0 | −6.8/-1.0 | 0.267 | |||
| static vs. MSt | 0.594 | 0.158 | ||||||
| Ankle kinetics | ||||||||
| Dorsiflexion moment in late stance phase (Nm/kg) | 1.3 | 1.1/1.4 | 1.4 | 1.3/1.5 | 0.037* | |||
| Power in late stance phase (W/kg) | 3.3 | 2.1/4.3 | 3.9 | 3.5/4.4 | 0.08 | |||
DF/PF, Dorsiflexion/plantarflexion; IV/EV, Inversion/eversion; SP/PR, Supination/pronation; AH, Arch height OFM; AI, Arch index; ROM, Range of motion; max, maximum; min, minimum; IC, Initial contact; LR, Loading response; MSt, Mid stance; TSt, Terminal Stance; PSw, Pre-swing
*Statistically significant as p < 0.05
Fig. 4Foot kinematics and kinetics. The solid red line (mean) represents the JIA pes planovalgus patients (JIA-PPV) and the red dotted line (mean) represents the healthy control group (CG) in static condition. In walking condition, the solid line (mean) with green shade (SD) represents JIA-PPV and the dotted line (mean) with gray shade (SD) represents CG. The maxima and the range between them are the points of interest. All angles were time-normalized to the percent of the gait cycle. The vertical lines divide stance and swing phase. Significant differences are indicated by p-value < 0.05